AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $49,263,000 | +139.6% | 823,251 | +12.5% | 0.06% | +124.0% |
| Q3 2019 | $20,559,000 | -8.4% | 731,902 | +23.4% | 0.02% | -10.7% |
| Q2 2019 | $22,449,000 | +112.1% | 592,947 | +118.6% | 0.03% | +100.0% |
| Q1 2019 | $10,582,000 | +255.5% | 271,191 | +94.2% | 0.01% | +250.0% |
| Q4 2018 | $2,977,000 | +15.5% | 139,641 | +114.5% | 0.00% | +33.3% |
| Q3 2018 | $2,578,000 | -15.2% | 65,112 | -18.1% | 0.00% | -25.0% |
| Q2 2018 | $3,039,000 | +157.1% | 79,531 | +102.2% | 0.00% | +100.0% |
| Q1 2018 | $1,182,000 | +71.1% | 39,337 | +77.9% | 0.00% | +100.0% |
| Q4 2017 | $691,000 | -62.3% | 22,116 | -66.2% | 0.00% | -66.7% |
| Q3 2017 | $1,831,000 | +41.7% | 65,352 | -3.2% | 0.00% | +50.0% |
| Q2 2017 | $1,292,000 | +123.5% | 67,526 | +98.9% | 0.00% | +100.0% |
| Q1 2017 | $578,000 | +57.9% | 33,942 | +69.6% | 0.00% | 0.0% |
| Q4 2016 | $366,000 | -37.4% | 20,008 | -39.1% | 0.00% | 0.0% |
| Q3 2016 | $585,000 | – | 32,870 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 767,502 | $45,927,000 | 23.65% |
| Chicago Capital Management, LLC | 250,401 | $14,984,000 | 12.57% |
| Foresite Capital Management III, LLC | 233,067 | $13,947,000 | 7.82% |
| Partner Investment Management, L.P. | 17,795 | $1,065,000 | 7.65% |
| RAMIUS ADVISORS LLC | 220,784 | $13,212,000 | 5.68% |
| Beryl Capital Management LLC | 550,426 | $32,937,000 | 5.31% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 647,460 | $38,744,000 | 5.28% |
| FNY Investment Advisers, LLC | 278,861 | $16,687,000 | 5.17% |
| WHITE SQUARE CAPITAL LLP | 112,500 | $6,732,000 | 4.87% |
| Casdin Capital, LLC | 860,000 | $51,462,000 | 4.73% |